Prof. Dr. Halina Baran | Neuroscience | Excellence Award (Any Scientific Field)
Researcher and leader at Karl Landsteiner Research Institute Mauer, 33 62 Mauer-Amstetten, Austris
Halina Baran, Ph.D., is a distinguished Austrian scientist renowned for her extensive contributions to neurochemistry, pharmacology, and biochemistry. Currently leading the Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation, and Pain Treatment in Mauer-Amstetten, her pioneering research in kynurenine metabolism and neurodegenerative disorders has earned her international acclaim.
Profile
Education 🎓
Dr. Baran completed her Master’s in Chemical Engineering at the Polytechnical University of Krakow, Poland (1976). She further pursued studies in Biochemistry and Pharmacology at the University of Vienna, earning her doctorate (Dr. techn.) in 1983. Her academic journey reflects a commitment to unraveling biochemical complexities.
Experience 💼
With over four decades of academic and research appointments, Dr. Baran has held esteemed roles, including Research Associate at the University of Vienna and Visiting Researcher at institutions like the University of Freiburg and the University of Maryland. Since 2011, she has served as the head of the Karl Landsteiner Research Institute, Austria.
Research Interests 🧪
Dr. Baran’s research spans behavioral neuroscience, kynurenine metabolism, neurodegeneration, and neuroprotection. Her focus includes exploring amino acid neurotransmitters, enzymology, and mitochondrial function in the context of neuroinflammatory and neurodegenerative disorders.
Awards 🏆
Dr. Baran has received numerous accolades, including the 1st Scientific Award of the Lower Austrian Medical Society (2005) for her groundbreaking work on kynurenic acid and the Research Award of the Lower Austrian Government (2014). These awards underscore her contributions to advancing neuroscience.
Publications 📚
Dr. Baran’s research has been published in prestigious journals. Notable works include:
- Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria
- Year: 2016
- Citations: 29
- Proliferation of Macrophages Due to the Inhibition of Inducible Nitric Oxide Synthesis by Oxidized Low-Density Lipoproteins
- Year: 2015
- Citations: 11
- Salivary Cortisol and Behavior in Therapy Dogs During Animal-Assisted Interventions: A Pilot Study
- Year: 2014
- Citations: 80
- D-cycloserine Lowers Kynurenic Acid Formation—New Mechanism of Action
- Year: 2014
- Citations: 12
- Therapy Dogs’ Salivary Cortisol Levels Vary During Animal-Assisted Interventions
- Year: 2013
- Citations: 65
- Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients
- Year: 2013
- Citations: 14
- Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia
- Year: 2023
- Citations: 2
- Increase of Kynurenic Acid after Encephalomyocarditis Virus Infection and Its Significances
- Year: 2021
- Citations: 1
- Kynurenine Aminotransferases I, II and III Are Present in Saliva
- Year: 2020
- Citations: 3
- Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus
- Year: 2019
- Citations: 5
Conclusion 🌟